Safety study of AAPB injection in healthy adults
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests an investigational injection called AAPB in healthy volunteers to see if it's safe and how the body processes it. Participating may help find early side effects and guide future doses for conditions it might treat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You need a body mass index (BMI) between 19 and 28, with a minimum weight of 50 kg for men and 45 kg for women.
- You must be generally healthy with no major medical conditions (heart, liver, kidney, etc.) and no history of mental illness or cancer.
- You must not have taken certain medications, herbal supplements, or participated in another clinical trial within the past 30 days to 3 months.
- You must not smoke heavily, drink heavily, or use recreational drugs.
- You must agree to use effective birth control during the study and for 3 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting information on how well the Penumbra System works and how safe it is when used to remove blood clots in people having a certain type of stroke. It is for patients who are eligible for mechanical thrombectomy (a procedure to remove the clot) using this device as the first treatment.
This trial tests a new medicine called HRS-4029 in healthy people to see how safe it is and how the body handles it. It is an early-stage study that may help in developing a treatment for future patients.
This trial tests an investigational injection called KPCXM18 for people having an acute ischemic stroke. It is given within 12 hours of symptom onset, in addition to standard clot-dissolving treatment, to see if it improves recovery and safety.
This trial tests a new way to deliver a medication called RK-4 directly into the skull bone marrow to bypass the blood-brain barrier for people with a major stroke on one side of the brain. The goal is to see if this injection is safe and feasible, and it might help reduce damage after a severe stroke.
This trial studies a protective “conditioning” treatment given during air ambulance transport for people with a suspected large-vessel ischemic stroke. The goal is to reduce further brain injury and preserve more brain tissue while you’re being transported for stroke care.
This trial tests a new oral medication called LWP779 in healthy adults to see if it is safe and how the body processes it. It helps determine the right dose for future studies.
Hear when a new Acute Ischemic Stroke (AIS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.